Dr. Joel Schilling of the WashU Cardiovascular Division was one of the authors of the cover story of the August edition of the Journal of Immunology, an article titled “Cutting Edge: Hepatic Stellate Cells Drive the Phenotype of Monocyte-derived Macrophages to Regulate Liver Fibrosis in Metabolic Dysfunction-associated Steatohepatitis “.
Dr. Schilling explains that the work is focused on “interplay between macrophages and stellate cells in Metabolic dysfunction-associated steatohepatitis (MASH).”
Read the article here.